Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label single-arm study of GC301 in infantile-onset Pompe disease
CTR20230819Phase 2Active
- Sponsor
- GeneCradle
- Start
- Jun 2023
- Modality
- Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of gc301 in Pompe disease, sponsored by GeneCradle. Started Jun 2023; status: active.
02
Drugs
gc301
03
Conditions
Pompe disease
Beyond the preview
Go deeper on CTR20230819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230819.